• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

July 24, 2024

Jacque's Post

 

(CONSUMERS ARE BEING SWINDLED IN THE BANKING WORLD)

July 24, 2024

 

Hello everyone,

Savings account traps:  why billions are disappearing

Research shows that Australian adults are losing an average of $1500 per person every year through using the wrong savings accounts.

The research paper by financial services technology company Upworth says consumers collectively miss out on about $30 billion in interest annually, often because of confusing accounts, information overload, or overconfidence.

It says cash deposits currently pay between 0% and 5.75%, and almost three-quarters of bonus interest savings accounts do not pay the bonus rate because savers don’t meet the conditions required.

Upworth illustrates the fact that complex product design often makes it hard to compare products.  The headline interest rate is a very different concept from the effective interest rate an individual earns. Base rates, bonus rates, and introductory rates all come in the mix. 

Upworth co-founder Maxime Chaury said people with deposits were lending money to their banks, and banks were trying to minimize their borrowing costs.

Chaury points out one of the easiest ways to do this is to make their product offering confusing and have as many low-interest-rate savings accounts as possible and as few high-interest-rate savings accounts.  And what that does is increase the chances you will end up with a low-interest rate account.

Chaury says that people had psychological biases that resulted in them earning less interest.

This included overconfidence, loss aversion, and preferring the status quo.  Information overload also played a role.  We all know that when we are faced with too many options and an overload of information, we are typically overwhelmed.  And rather than engage with any complexity, we are likely to default to inaction.  And the banks are counting on that behaviour.

Chaury said conditions attached to many accounts – such as minimum monthly deposits or limited withdrawals – could drastically reduce interest, while introductory interest rates were only temporary, typically three to six months.

Banks understand many people will never change their savings account, despite the rate dropping significantly after the introductory period.

Savings rates are littered with fine print (that many people never read), designed to limit the amount of interest a bank has to pay its customers, from balance-based rate tiers, age minimums and maximums, and monthly bonus rate conditions.

There are millions of big bank online saver customers who signed up for an introductory rate five or ten years ago, which gave them a higher interest rate for the first few months or so and have now been earning next to nothing for years because they haven’t been bothered to switch to a more competitive account.

 

 

Australians aren’t the only ones confused about their Savings Accounts.

 

The largest cybersecurity breach in Australian history

Cybersecurity experts say the highly sensitive data of 12.9 million Australians, stolen from eScripts provider Medi Secure, has already been sold on the dark web and is up for sale again.

MediSecure confirmed in May it was the victim of a ransomware attack in 2023 and last week revealed the scale of the breach, which puts it among the largest in Australian history.

Data stolen includes names, phone numbers, addresses, and Medicare numbers, as well as sensitive medical information such as which drugs people had been prescribed and why they were taking them.  It was previously unclear if the data had been sold, but cyber threat intelligence analysts say there’s a strong indication that at least one sale has taken place.

 

 

 

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-24 12:00:112024-07-24 11:50:26July 24, 2024
april@madhedgefundtrader.com

Trade Alert - (TSLA) July 24, 2024 - TAKE PROFITS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-24 11:04:002024-07-24 11:04:00Trade Alert - (TSLA) July 24, 2024 - TAKE PROFITS - SELL
april@madhedgefundtrader.com

July 24, 2024

Diary, Newsletter, Summary

Global Market Comments
July 24, 2024
Fiat Lux

 

Featured Trade:

(WHAT AI CAN AND CAN’T DO FOR YOU)
(AAPL), (GOOGL), (AMZN), (AMZN), (TSLA), (NVDA), (MU)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-24 09:04:292024-07-24 14:05:40July 24, 2024
april@madhedgefundtrader.com

July 23, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
July 23, 2024
Fiat Lux

 

Featured Trade:

(DON'T SLEEP ON THIS BIOTECH SLEEPER)

(ATHA), (BIIB), (LLY)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-23 12:02:502024-07-23 11:44:36July 23, 2024
april@madhedgefundtrader.com

Don't Sleep On This Biotech Sleeper

Biotech Letter

To date, 6.7 million Americans over 65 are already wrestling with Alzheimer's, a number set to double by 2050.

It's a demographic disaster, a slow-motion train wreck that Big Pharma's been slow to recognize.

Companies, including Biogen (BIIB) and Eli Lilly (LLY), working on this are still fiddling with amyloid plaques and tangled proteins, like a plumber trying to fix a leaky nuclear reactor with duct tape.

But one scrappy biotech outfit, Athira Pharma (ATHA), is taking a different tack. They're not chasing the same old tired targets.

Instead, they're looking at the brain's own repair mechanisms, trying to kickstart the engine instead of just patching up the exhaust. It's a high-risk, high-reward play, but isn't that what makes this game so damn exciting?

Athira targets the neurotrophic hepatocyte growth factor (HGF) and its sidekick, the MET receptor. Don't let the fancy names fool you - these little fellas are the unsung heroes of your noggin.

Think of HGF and MET as the brain's maintenance crew. They're not just sitting around twiddling their thumbs. They're constantly on the job, patching up neurons and keeping the lights on upstairs.

Athira's betting the farm that if they can juice up this dynamic duo, they might just be able to slow down the Alzheimer's wrecking ball, or heck, maybe even throw it in reverse.

It's a bold move, I'll give 'em that. While everyone else is trying to sweep up the mess Alzheimer's leaves behind, Athira's aiming to stop the party before it even starts.

If they're right, it could be like discovering fire all over again in the world of neuroscience.

Speaking of which, Athira's lead drug, fosgonimeton (try saying that three times fast), just hit a milestone that's got Wall Street perking up its ears. They've wrapped up dosing in their Phase 2/3 LIFT-AD trial for mild-to-moderate Alzheimer's.

We're talking about 315 patients who've been getting daily shots of this stuff (or a placebo) for 26 weeks. It's like a six-month-long neuroscience party, and we're all waiting to see who's left standing when the lights come on.

Interestingly, Athira's playing it smart with their ongoing Phase 2/3 LIFT-AD trial. They're using something called the Global Statistical Test (GST) as their primary endpoint. It's like they're giving themselves better odds at the casino.

This GST is designed to catch even the slightest whiff of a clinically meaningful treatment effect. It's like using a finely-tuned bloodhound instead of a myopic poodle to find your car keys.

And here's another thing that caught my attention: 85% of the folks from their trials signed up for the after-party - the open-label extension study. That's like people sticking around to help clean up after a rager.

When was the last time you saw that kind of enthusiasm for anything, let alone a clinical trial?

But Athira isn't content with just one target. They've also got fosgonimeton in the ring against Parkinson's with their SHAPE trial.

This Phase 2 slugfest has already shown some positive jabs on cognitive measures for patients with Parkinson's disease dementia and Dementia with Lewy bodies.

And because apparently two fights aren't enough, Athira's also thrown fosgonimeton into the ALS arena. This early-stage trial is like watching a fighter warming up in the gym - we don't know how it'll play out, but the potential is intriguing.

So, what’s next? Well, we’re now staring down the barrel of what could be the biggest shakeup in Alzheimer's research since... well, since we started researching Alzheimer's.

Athira's betting big on their HGF/MET approach, and if it pays off, we might be looking at the medical equivalent of striking oil in your backyard.

Mark your calendars for the end of Q3 2024. That's when we'll find out if fosgonimeton is the real McCoy or just another pie-in-the-sky biotech dream. And don't forget the fireworks show in Madrid this October - Athira's set to strut their stuff at the Alzheimer's conference, and you can bet your bottom dollar I'll be watching.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-23 12:00:022024-07-23 11:44:14Don't Sleep On This Biotech Sleeper
april@madhedgefundtrader.com

July 23, 2024

Diary, Newsletter, Summary

Global Market Comments
July 23, 2024
Fiat Lux

 

Featured Trade:

(SOME SAGE ADVICE ON ASSET ALLOCATION)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-23 09:04:282024-07-23 12:41:32July 23, 2024
Douglas Davenport

Some Sage Advice About Asset Allocation

Diary, Newsletter

Asset allocation is the one question that I get every day, which I absolutely cannot answer.

The reason is simple: no two investors are alike.

The answer varies whether you are young or old, have $1,000 in the bank or $1 billion, are a sophisticated investor or an average Joe, are in the top or the bottom tax bracket, and so on.

This is something you should ask your financial advisor if you haven’t fired him already, which you probably should.

Having said all that, there is one old hard and fast rule, which you should probably follow.

It is prudent to own your age in bonds. So, if you were 70, you should have had 70% of your assets in fixed-income instruments and 30% in equities.

That’s a lot easier to do today because 90-day T-bills yield an astonishing 5.4% while ten-year bonds bring in 3.6%.

You can also add high dividend-paying stocks for bonds. You can get 5% a year or more in yields these days, and get a great inflation hedge, to boot. Crown Castle International (CCI) is now paying a 5.5% dividend and last time I checked they are still building 5G cell phone towers, (CCI)’s specialty.

You will also own what everyone else in the world is trying to buy right now, high growth US stocks, the big FANG’s.

You will get this higher return at the expense of higher volatility. So just turn the TV off on the down days so you won’t get panicked out at the bottom.

That is until we hit the next recession. Then all bets are off.

I hope this helps.

John Thomas
The Diary of a Mad Hedge Fund Trader

 

It's Time for the Wakeup Call

https://www.madhedgefundtrader.com/wp-content/uploads/2022/05/jtsleep.png 323 403 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2024-07-23 09:02:352024-07-23 12:41:11Some Sage Advice About Asset Allocation
Mad Hedge Fund Trader

July 23, 2024 - Quote of the Day

Diary, Newsletter, Quote of the Day

“The bubble is in the bond market, not the stock market,” said Leon Cooperman, CEO of Omega Advisors, an original investor in my 1990s hedge fund.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2020/01/leon-copperman.png 272 410 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-07-23 09:00:162024-07-23 12:40:52July 23, 2024 - Quote of the Day
Douglas Davenport

Artificial Intelligence, financial management and sales & use tax audits

Mad Hedge AI

Artificial Intelligence (AI) is poised to revolutionize various sectors, and its impact on financial management and sales & use tax audits is rapidly gaining momentum. The integration of AI technologies is streamlining processes, enhancing accuracy, and unlocking valuable insights, ultimately transforming the landscape of tax compliance. This comprehensive article delves into the multifaceted ways in which AI is reshaping financial management and audits in the realm of sales & use taxes.

  1. Automating Data Collection and Analysis

One of the most significant contributions of AI lies in its ability to automate the collection and analysis of vast datasets. Traditionally, financial professionals and auditors spent countless hours manually sifting through invoices, receipts, and transaction records to ensure accurate tax calculations. AI-powered tools can swiftly process this data, identifying discrepancies, flagging potential errors, and ensuring compliance with complex tax regulations. This not only saves time but also minimizes the risk of human error, leading to more precise tax filings.

  1. Enhancing Risk Assessment and Fraud Detection

AI algorithms excel at pattern recognition and anomaly detection. In the context of sales & use tax audits, this capability is invaluable. AI can analyze historical data to identify trends and outliers, alerting auditors to potential instances of fraud or non-compliance. By proactively flagging suspicious activities, AI enables auditors to focus their efforts on high-risk areas, increasing the efficiency and effectiveness of audits.

  1. Streamlining Audit Processes

The audit process itself is undergoing a transformation thanks to AI. AI-powered tools can automate various audit tasks, such as data extraction, reconciliation, and report generation. This not only accelerates the audit timeline but also frees up auditors to concentrate on more complex tasks that require human judgment and expertise. Additionally, AI can assist in identifying areas where businesses can optimize their tax strategies, leading to potential cost savings.

  1. Real-time Compliance Monitoring

AI facilitates real-time monitoring of sales & use tax compliance. By continuously analyzing transaction data, AI can alert businesses to potential issues as they arise, allowing for immediate corrective action. This proactive approach minimizes the risk of penalties and ensures that businesses remain compliant with ever-changing tax laws. Furthermore, real-time monitoring enables businesses to adapt their tax strategies dynamically, optimizing their tax positions.

  1. Predictive Analytics for Tax Planning

AI's predictive capabilities extend to tax planning. By analyzing historical data and market trends, AI algorithms can forecast potential tax liabilities and identify opportunities for tax optimization. This empowers businesses to make informed decisions about their financial strategies, minimizing tax burdens and maximizing profitability. Predictive analytics also aids in scenario planning, allowing businesses to assess the tax implications of various courses of action.

  1. Natural Language Processing (NLP) for Tax Research

Tax laws are notoriously complex and subject to frequent updates. AI-powered NLP tools can sift through vast volumes of legal documents and tax codes, extracting relevant information and summarizing it in a digestible format. This empowers tax professionals to stay abreast of the latest regulations and ensure compliance with minimal effort. NLP also facilitates the automation of tax research tasks, saving valuable time and resources.

  1. Chatbots and Virtual Assistants for Customer Support

AI-powered chatbots and virtual assistants are enhancing customer support in the realm of sales & use taxes. These intelligent agents can answer common tax-related queries, guide customers through the filing process, and provide personalized assistance. By automating routine customer interactions, businesses can improve response times, reduce support costs, and enhance the overall customer experience.

  1. Challenges and Considerations

While the potential benefits of AI in financial management and sales & use tax audits are undeniable, several challenges and considerations warrant attention. These include data privacy concerns, the need for skilled AI professionals, the potential for bias in AI algorithms, and the ethical implications of AI-driven decision-making. Addressing these challenges will be crucial to harnessing the full potential of AI in this domain.

  1. The Future of AI in Sales & Use Tax Audits

The future of AI in sales & use tax audits is incredibly promising. As AI technologies continue to evolve, we can anticipate even more sophisticated applications, such as:

  • Explainable AI: AI models that can provide transparent explanations for their decisions, enhancing trust and accountability.
  • Generative AI: AI models that can generate tax reports, summaries, and even legal documents, further automating the audit process.
  • Hyper-personalization: AI-driven tax advice tailored to the specific needs and circumstances of individual businesses.

Conclusion

AI is revolutionizing financial management and sales & use tax audits, ushering in an era of enhanced efficiency, accuracy, and compliance. From automating mundane tasks to providing real-time insights and predictive analytics, AI is transforming the way businesses approach tax compliance. While challenges remain, the potential benefits are undeniable, and the future of AI in this field is bright. Embracing AI technologies will be essential for businesses seeking to thrive in the ever-evolving landscape of sales & use taxes.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2024-07-22 16:53:152024-07-23 12:51:25Artificial Intelligence, financial management and sales & use tax audits
april@madhedgefundtrader.com

July 22, 2024

Tech Letter

Mad Hedge Technology Letter
July 22, 2024
Fiat Lux

 

Featured Trade:

(THE EV CONUNDRUM)
(TSLA), (RIVN), (TOYOTA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-07-22 14:04:182024-07-22 16:29:45July 22, 2024
Page 5 of 15«‹34567›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top